相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effects of antidiabetics and exercise therapy on suppressors of cytokine signaling-1, suppressors of cytokine signaling-3, and insulin receptor substrate-1 molecules in diabetes and obesity
Ersin Akarsu et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2023)
Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes A Randomized Clinical Trial
Gregory P. Forlenza et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)
Beauty and the beast: host microRNA-155 versus SARS-CoV-2
K. I. Papadopoulos et al.
HUMAN CELL (2023)
AT1 receptor downregulation: A mechanism for improving glucose homeostasis
Diana L. Lopez et al.
WORLD JOURNAL OF DIABETES (2023)
Dissecting miRNA-Gene Networks to Map Clinical Utility Roads of Pharmacogenomics-Guided Therapeutic Decisions in Cardiovascular Precision Medicine
Fani Chatzopoulou et al.
CELLS (2022)
Allele C (rs5186) of at1r is associated with the severity of COVID-19 in the Ukrainian population
O. Izmailova et al.
INFECTION GENETICS AND EVOLUTION (2022)
Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: A meta-analysis
Honglei Hu et al.
PLOS ONE (2022)
Identification of the shared gene signatures and pathways between sarcopenia and type 2 diabetes mellitus
Shiyuan Huang et al.
PLOS ONE (2022)
A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 Diabetes
Chih-Yuan Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients
Agnieszka Magdalena Borowiec et al.
Medicine and Pharmacy Reports (2022)
Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review
Wang-Dong Xu et al.
INFLAMMATION RESEARCH (2022)
Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview
P. A. D. S. Palihaderu et al.
EPIGENETICS INSIGHTS (2022)
Study on the correlation between PPARγ, Aβ1-42, miR-155 and the occurrence and development of diabetes
Lv Zhiping et al.
CELLULAR AND MOLECULAR BIOLOGY (2021)
Metformin regulates inflammation and fibrosis in diabetic kidney disease through TNC/TLR4/NF-κB/miR-155-5p inflammatory loop
Yang Zhou et al.
WORLD JOURNAL OF DIABETES (2021)
A systematic review and meta-analysis of effects of spironolactone on blood pressure, glucose, lipids, renal function, fibrosis and inflammation in patients with hypertension and diabetes
Mengyue Lin et al.
BLOOD PRESSURE (2021)
Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials
Jia Yao et al.
PLOS ONE (2021)
Functional Role of miR-155 in the Pathogenesis of Diabetes Mellitus and Its Complications
Stanislovas S. Jankauskas et al.
NON-CODING RNA (2021)
Mechanism of increased risk of insulin resistance in aging skeletal muscle
Jian Shou et al.
DIABETOLOGY & METABOLIC SYNDROME (2020)
High fat-induced inflammation in vascular endothelium can be improved by Abelmoschus esculentus and metformin via increasing the expressions of miR-146a and miR-155
Luoning Gou et al.
NUTRITION & METABOLISM (2020)
Arginine and Endothelial Function
Jessica Gambardella et al.
BIOMEDICINES (2020)
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
MicroRNAs as Biomarkers of Systemic Changes in Response to Endurance Exercise-A Comprehensive Review
Aleksandra Soplinska et al.
DIAGNOSTICS (2020)
Genome-wide association analysis of type 2 diabetes in the EPIC-InterAct study
Lina Cai et al.
SCIENTIFIC DATA (2020)
MicroRNA-155: A Master Regulator of Inflammation
Guruswamy Mahesh et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
Understanding the mechanisms of reversal of type 2 diabetes
Roy Taylor et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
A common polymorphism in MIR155 gene promoter region is associated with a lower risk to develop type 2 diabetes
Andrea Latini et al.
ACTA DIABETOLOGICA (2019)
Decreased Serum Level of miR-155 is Associated with Obesity and its Related Metabolic Traits
Roya Mahdavi et al.
CLINICAL LABORATORY (2018)
MicroRNA expression profile in plasma from type 1 diabetic patients: Case-control study and bioinformatic analysis
Tais S. Assmann et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Modulation of the renin-angiotensin system in white adipose tissue and skeletal muscle: focus on exercise training
Eliete Dalla Corte Frantz et al.
CLINICAL SCIENCE (2018)
Circulating Adipocyte-Derived Exosomal MicroRNAs Associated with Decreased Insulin Resistance After Gastric Bypass
Monica J. Hubal et al.
OBESITY (2017)
Hyperlipidemia-Induced MicroRNA-155-5p Improves β-Cell Function by Targeting Mafb
Mengyu Zhu et al.
DIABETES (2017)
Polymorphisms in genes encoding miR-155 and miR-146a are associated with protection to type 1 diabetes mellitus
Tais S. Assmann et al.
ACTA DIABETOLOGICA (2017)
miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy
Yong Yang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
MiR-155 Enhances Insulin Sensitivity by Coordinated Regulation of Multiple Genes in Mice
Xiaolin Lin et al.
PLOS GENETICS (2016)
Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging
Jennifer J. DuPont et al.
JCI INSIGHT (2016)
Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?
Flavio Danni Fuchs et al.
OPEN HEART (2015)
microRNA-155 is inversely associated with severity of coronary stenotic lesions calculated by the Gensini score
Guo-fu Zhu et al.
CORONARY ARTERY DISEASE (2014)
Repression of Arginase-2 Expression in Dendritic Cells by MicroRNA-155 Is Critical for Promoting T Cell Proliferation
Isabelle Dunand-Sauthier et al.
JOURNAL OF IMMUNOLOGY (2014)
Dysregulated miR-155 Expression in Peripheral Blood Mononuclear Cells from Patients with Type 2 Diabetes
N. E. Corral-Fernandez et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2013)
Regulation of the MIR155 host gene in physiological and pathological processes
Terry S. Elton et al.
GENE (2013)
Preventing β-Cell Loss and Diabetes With Calcium Channel Blockers
Guanlan Xu et al.
DIABETES (2012)
Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration
Ni Zhu et al.
ATHEROSCLEROSIS (2011)
microRNA-155 regulates angiotensin II type 1 receptor expression in umbilical vein endothelial cells from severely pre-eclamptic pregnant women
Weiwei Cheng et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2011)
MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB
Martina Weber et al.
CARDIOLOGY RESEARCH AND PRACTICE (2011)
MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts
Liang Zheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
miR-155 gene: A typical multifunctional microRNA
Isabella Faraoni et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells
A. C. Breggia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region:: A mechanism for functional single-nucleotide polymorphisms related to phenotypes
Praveen Sethupathy et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling
YM Zhan et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)